Prothena | PRTA - Trade Debtors


Prothena reported $5.16M in Trade Debtors for its fiscal quarter ending in December of 2023.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 139.44M 19.75M Sep/2025
Agios Pharmaceuticals USD 5.03M 43K Sep/2025
ALKERMES USD 355.11M 1.22M Sep/2025
Alnylam Pharmaceuticals USD 964.77M 397.66M Sep/2025
Amgen USD 8.49B 211M Sep/2025
Biogen USD 1.85B 234M Sep/2025
BioMarin Pharmaceutical USD 790.27M 65.59M Sep/2025
Exelixis USD 311.3M 17.42M Sep/2025
Incyte USD 895.89M 53M Sep/2025
Ionis Pharmaceuticals USD 24.61M 27.97M Sep/2025
MacroGenics USD 69.23M 56.7M Sep/2025
Neurocrine Biosciences USD 728M 132.3M Sep/2025
Prothena USD 5.16M 0 Dec/2023
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Ultragenyx Pharmaceutical USD 112.54M 11.92M Sep/2025
Vertex Pharmaceuticals USD 1.95B 52.9M Sep/2025